In Brief
This article was originally published in The Tan Sheet
Executive Summary
CDER clarifies toll-free number labeling; FTC consent decree edit fails in Garden of Life case; NAD rules on Ranir’s Abridge ad; POM Wonderful, FTC plot appeals of ALJ decision; more news In Brief.
You may also be interested in...
Regulatory News In Brief
FTC/Garden of Life case continues; FDA deems ForMor in violation of GMPs; Kanebo faulted for pharmaceutical GMP failures; CytoSport settles litigation over Muscle Milk labeling; USPlabs’ carb claim canned in NAD review; FDA extends comment time on FSMA tracking pilots.
Regulatory News In Brief
FTC/Garden of Life case continues; FDA deems ForMor in violation of GMPs; Kanebo faulted for pharmaceutical GMP failures; CytoSport settles litigation over Muscle Milk labeling; USPlabs’ carb claim canned in NAD review; FDA extends comment time on FSMA tracking pilots.
Judge Knocks Down FTC Substantiation Bar In POM Wonderful Case
An FTC administrative law judge says the agency cannot require randomized controlled trials to substantiate nutrient claims. POM Wonderful calls the decision “a huge win,” but the firm still received a cease-and-desist order for its pomegranate juice and supplement claims.